Hansen P R
Medicinsk afdeling B, Rigshospitalet, København.
Ugeskr Laeger. 1996 May 6;158(19):2706-10.
The "oxidation hypothesis" states that oxidised low-density lipoprotein (ox-LDL) plays a central role in atherogenesis. LDL oxidation is a chaotic process initiated by reactive oxygen species. Enhanced uptake of ox-LDL in macrophages leads to foam cell formation in vitro, and ox-LDL has a variety of other experimental proatherogenic effects, e.g., endothelial cell activation, immunogenicity, platelet aggregation, and inhibition of endothelium-dependent vaso-relaxation. There are methodological limitations in the current laboratory methods aimed at characterization of the oxidative state of LDL. However, considerable evidence indicates that ox-LDL is found in plasma, arteries, and atheromatous plaques of humans, although the significance of this phenomenon is unknown. Antioxidants may inhibit atherosclerosis in experimental animals, and epidemiological data suggest an inverse relation between the intake of antioxidant vitamins and the risk of coronary artery disease. Randomised prospective trials are in progress, and until their conclusion, the clinical effect of antioxidant therapy in man remains unknown.
“氧化假说”认为,氧化型低密度脂蛋白(ox-LDL)在动脉粥样硬化形成过程中起核心作用。LDL氧化是一个由活性氧引发的无序过程。巨噬细胞对ox-LDL摄取的增强导致体外泡沫细胞形成,并且ox-LDL具有多种其他实验性促动脉粥样硬化作用,例如内皮细胞活化、免疫原性、血小板聚集以及抑制内皮依赖性血管舒张。目前旨在表征LDL氧化状态的实验室方法存在方法学局限性。然而,大量证据表明,在人类的血浆、动脉和动脉粥样斑块中发现了ox-LDL,尽管这一现象的意义尚不清楚。抗氧化剂可能在实验动物中抑制动脉粥样硬化,并且流行病学数据表明抗氧化维生素的摄入量与冠状动脉疾病风险之间呈负相关。随机前瞻性试验正在进行中,在其得出结论之前,抗氧化治疗对人类的临床效果仍然未知。